Would you like to know more about the GOLDEN study? Contact Us

What is the GOLDEN study?

GOLDEN is a clinical study of an investigational antisense drug for the treatment of geographic atrophy (GA) due to age-related macular degeneration (AMD). The study will help determine the safety and effectiveness of the potential new treatment in slowing the progression of GA caused by AMD.